INFINITY PHARMACEUTICALS INC's ticker is INFI and the CUSIP is 45665G303. A total of 45 filers reported holding INFINITY PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $37,346,000 | +128679.3% | 31,920 | -0.6% | 0.01% | +20.0% |
| Q2 2020 | $29,000 | +7.4% | 32,120 | 0.0% | 0.01% | -16.7% |
| Q1 2020 | $27,000 | -99.9% | 32,120 | +4.6% | 0.01% | +20.0% |
| Q4 2019 | $29,467,000 | +81752.8% | 30,695 | -12.6% | 0.01% | -28.6% |
| Q3 2019 | $36,000 | -70.2% | 35,120 | -47.9% | 0.01% | -70.8% |
| Q2 2019 | $121,000 | -11.0% | 67,380 | -6.9% | 0.02% | -14.3% |
| Q1 2019 | $136,000 | +54.5% | 72,380 | -3.3% | 0.03% | +40.0% |
| Q4 2018 | $88,000 | -56.0% | 74,880 | -23.3% | 0.02% | -50.0% |
| Q3 2018 | $200,000 | +9.3% | 97,630 | +2.1% | 0.04% | +17.6% |
| Q2 2018 | $183,000 | +2.8% | 95,630 | +13.0% | 0.03% | -2.9% |
| Q1 2018 | $178,000 | -42.9% | 84,630 | -45.0% | 0.04% | -40.7% |
| Q4 2017 | $312,000 | – | 153,800 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 6,575,000 | $21,237,000 | 2.26% |
| AIGH Capital Management LLC | 1,650,256 | $5,330,000 | 1.12% |
| BVF INC/IL | 8,383,645 | $27,079,000 | 1.02% |
| GUARDIAN POINT CAPITAL, LP | 1,200,000 | $3,876,000 | 0.97% |
| Tri Locum Partners LP | 1,210,863 | $3,911,000 | 0.97% |
| Altium Capital Management LP | 972,327 | $3,141,000 | 0.87% |
| Worth Venture Partners, LLC | 387,141 | $1,250,000 | 0.61% |
| DAFNA Capital Management LLC | 459,260 | $1,483,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 530,000 | $1,712,000 | 0.33% |
| KNIGHTSBRIDGE ASSET MANAGEMENT, LLC | 173,110 | $559,000 | 0.24% |